Review. Development, Applications, Benefits, Challenges and Limitations of the New Genome Engineering Technique. An Update Study-Reference-Cited by-同舟云学术

Review. Development, Applications, Benefits, Challenges and Limitations of the New Genome Engineering Technique. An Update Study

Published:2017-03-01 Issue:1 Volume:63 Page:4-9
ISSN:2247-6113
Container-title:Acta Medica Marisiensis
language:en
Short-container-title:

Author:

Crauciuc Andrei¹,Tripon Florin¹,Gheorghiu Andreea¹,Nemes Georgiana¹,Boglis Alina¹,Banescu Claudia²³

Affiliation:

1. University of Medicine and Pharmacy Tirgu Mures, Romania

2. University of Medicine and Pharmacy Tirgu Mures, Romania Romania

3. Center for Advanced Medical and Pharmaceutical Research, University of Medicine and Pharmacy Tirgu Mureș, Romania

Abstract

Abstract We assume that the CRISPR Cas9 theory must be delimited by applicability, because the consequences of long term DNA manipulation remain unknown. Moreover, the irreversibility of this procedure should instigate researchers to reserved opinions. Usefulness as well as benefits of CRISPR Cas9 made it one of the most popular and used genome editing technique. But with its huge potential, ethical and safety concerns emerge. Therefore, before continuing research in this direction we should have a well organized system that is able to make that differentiation between research and reproduction. However we truly believe in the future of genetic engineering and with the CRISPR-Cas9 system we expect that the opportunity of treating now so called incurable diseases arises. Time is all we need.

Publisher

Walter de Gruyter GmbH

Subject

General Pharmacology, Toxicology and Pharmaceutics,General Dentistry

Reference57 articles.

1. 1. Yang GK, Jooyen C, Srinivasan C. Hybrid restriction enzymes: Zinc finger fusions to Fok I cleavage domain. Proc Natl Acad Sci USA. 1996;93:1156-1160.

2. 2. Carroll D, Charo RA. The societal opportunities and challenges of genome editing. Genome Biology. 2015;16(1):1-9.

3. 3. Xue HY, Ji LJ, Gao AM, Liu P, He JD, Lu XJ. CRISPR-Cas9 for medical genetic screens: applications and future perspectives. J Med Genet. 2016;53:91-97.

4. 4. Ishino Y, Shinagawa H, Makino K, Amemura M, Nakata A. Nucleotide sequence of the iap gene, responsible for alkaline phosphatase isozyme conversion in Escherichia coli, and identification of the gene product. J Bacteriol. 1987;169:5429-5433.

5. 5. Makarova SK, Haft DH, Barrangou R. Evolution and classification of the CRISPR-Cas systems. Nat Rev Microbiol. 2011;9:467-477.

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Aptamer-Based Enforced Phosphatase-Recruiting Chimeras Inhibit Receptor Tyrosine Kinase Signal Transduction;Journal of the American Chemical Society;2024-08-01

2. From Descriptive to Functional Genomics of Leukemias Focusing on Genome Engineering Techniques;International Journal of Molecular Sciences;2021-09-17

3. CRISPR-dCas9-Based Artificial Transcription Factors to Improve Efficacy of Cancer Treatment With Drug Repurposing: Proposal for Future Research;Frontiers in Oncology;2021-02-03

4. Methods to label, image, and analyze the complex structural architectures of microvascular networks;Microcirculation;2019-01-17

5. Metazoan Parasite Vaccines: Present Status and Future Prospects;Frontiers in Cellular and Infection Microbiology;2018-03-13